210 related articles for article (PubMed ID: 21632457)
1. Cutaneous melanoma in situ: translational evidence from a large population-based study.
Mocellin S; Nitti D
Oncologist; 2011; 16(6):896-903. PubMed ID: 21632457
[TBL] [Abstract][Full Text] [Related]
2. Dermoscopic criteria for melanoma in situ are similar to those for early invasive melanoma.
Pizzichetta MA; Argenziano G; Talamini R; Piccolo D; Gatti A; Trevisan G; Sasso G; Veronesi A; Carbone A; Soyer HP
Cancer; 2001 Mar; 91(5):992-7. PubMed ID: 11251951
[TBL] [Abstract][Full Text] [Related]
3. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.
Huang KP; Weinstock MA; Clarke CA; McMillan A; Hoppe RT; Kim YH
Arch Dermatol; 2007 Jan; 143(1):45-50. PubMed ID: 17224541
[TBL] [Abstract][Full Text] [Related]
4. Risk of second primary malignancies following cutaneous melanoma diagnosis: a population-based study.
Spanogle JP; Clarke CA; Aroner S; Swetter SM
J Am Acad Dermatol; 2010 May; 62(5):757-67. PubMed ID: 20223559
[TBL] [Abstract][Full Text] [Related]
5. Subsequent primary cancers among men and women with in situ and invasive melanoma of the skin.
Balamurugan A; Rees JR; Kosary C; Rim SH; Li J; Stewart SL
J Am Acad Dermatol; 2011 Nov; 65(5 Suppl 1):S69-77. PubMed ID: 22018070
[TBL] [Abstract][Full Text] [Related]
6. Cancer incidence rates among Lawrence Livermore National Laboratory (LLNL) employees: 1974-1997.
Whorton MD; Moore DN; Seward JP; Noonan KA; Mendelsohn ML
Am J Ind Med; 2004 Jan; 45(1):24-33. PubMed ID: 14691966
[TBL] [Abstract][Full Text] [Related]
7. The characterization and potential impact of melanoma cases with unknown thickness in the United States' Surveillance, Epidemiology, and End Results Program, 1989-2008.
Shaikh WR; Weinstock MA; Halpern AC; Oliveria SA; Geller AC; Dusza SW
Cancer Epidemiol; 2013 Feb; 37(1):64-70. PubMed ID: 22995853
[TBL] [Abstract][Full Text] [Related]
8. Distribution of subsequent primary invasive melanomas following a first primary invasive or in situ melanoma Queensland, Australia, 1982-2010.
Youlden DR; Youl PH; Soyer HP; Aitken JF; Baade PD
JAMA Dermatol; 2014 May; 150(5):526-34. PubMed ID: 25093216
[TBL] [Abstract][Full Text] [Related]
9. Results of surveillance programme aimed at early diagnosis of cutaneous melanoma in high risk Mediterranean subjects.
Carli P; Balzi D; de Giorgi V; Massi D; Palli D; Chiarugi A; Nardini P; Giannotti B
Eur J Dermatol; 2003; 13(5):482-6. PubMed ID: 14693495
[TBL] [Abstract][Full Text] [Related]
10. The risk of melanoma in patients with chronic lymphocytic leukemia; a population-based study.
Turk T; Saad AM; Al-Husseini MJ; Gad MM
Curr Probl Cancer; 2020 Apr; 44(2):100511. PubMed ID: 32115255
[TBL] [Abstract][Full Text] [Related]
11. Increased melanoma risk in Parkinson disease: a prospective clinicopathological study.
Bertoni JM; Arlette JP; Fernandez HH; Fitzer-Attas C; Frei K; Hassan MN; Isaacson SH; Lew MF; Molho E; Ondo WG; Phillips TJ; Singer C; Sutton JP; Wolf JE;
Arch Neurol; 2010 Mar; 67(3):347-52. PubMed ID: 20212233
[TBL] [Abstract][Full Text] [Related]
12. Risk of Second Primary Cancer in Survivors of In Situ Melanoma.
Kimlin MG; Youlden DR; Brodie AM; DiSipio T; Youl P; Nair-Shalliker V; Baade PD
J Invest Dermatol; 2019 Apr; 139(4):842-847. PubMed ID: 30423330
[TBL] [Abstract][Full Text] [Related]
13. Age-Specific Incidence of Melanoma in the United States.
Paulson KG; Gupta D; Kim TS; Veatch JR; Byrd DR; Bhatia S; Wojcik K; Chapuis AG; Thompson JA; Madeleine MM; Gardner JM
JAMA Dermatol; 2020 Jan; 156(1):57-64. PubMed ID: 31721989
[TBL] [Abstract][Full Text] [Related]
14. Trends in incidence of primary cutaneous malignancies in children, adolescents, and young adults: a population-based study.
Senerchia AA; Ribeiro KB; Rodriguez-Galindo C
Pediatr Blood Cancer; 2014 Feb; 61(2):211-6. PubMed ID: 24174376
[TBL] [Abstract][Full Text] [Related]
15. Mutual Risks of Cutaneous Melanoma and Specific Lymphoid Neoplasms: Second Cancer Occurrence and Survival.
Herr MM; Schonfeld SJ; Dores GM; Withrow DR; Tucker MA; Curtis RE; Morton LM
J Natl Cancer Inst; 2018 Nov; 110(11):1248-1258. PubMed ID: 29659938
[TBL] [Abstract][Full Text] [Related]
16. An initial melanoma diagnosis may increase the subsequent risk of prostate cancer: Results from the New South Wales Cancer Registry.
Cole-Clark D; Nair-Shalliker V; Bang A; Rasiah K; Chalasani V; Smith DP
Sci Rep; 2018 May; 8(1):7167. PubMed ID: 29740153
[TBL] [Abstract][Full Text] [Related]
17. Shorter survival and later stage at diagnosis among unmarried patients with cutaneous melanoma: A US national and tertiary care center study.
Rachidi S; Deng Z; Sullivan DY; Lipson EJ
J Am Acad Dermatol; 2020 Oct; 83(4):1012-1020. PubMed ID: 32446825
[TBL] [Abstract][Full Text] [Related]
18. Increased incidence of malignant melanoma and other rare cutaneous cancers in the setting of chronic lymphocytic leukemia.
Brewer JD; Shanafelt TD; Call TG; Cerhan JR; Roenigk RK; Weaver AL; Otley CC
Int J Dermatol; 2015 Aug; 54(8):e287-93. PubMed ID: 25772131
[TBL] [Abstract][Full Text] [Related]
19. The influence of marital status on stage at diagnosis and survival of older persons with melanoma.
Reyes Ortiz CA; Freeman JL; Kuo YF; Goodwin JS
J Gerontol A Biol Sci Med Sci; 2007 Aug; 62(8):892-8. PubMed ID: 17702882
[TBL] [Abstract][Full Text] [Related]
20. Trends in the diagnosis and clinical features of melanoma in situ (MIS) in US men and women: A prospective, observational study.
Wei EX; Qureshi AA; Han J; Li TY; Cho E; Lin JY; Li WQ
J Am Acad Dermatol; 2016 Oct; 75(4):698-705. PubMed ID: 27436155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
